IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.500
-0.030 (-1.96%)
Apr 29, 2026, 11:32 AM EDT - Market open
IN8bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -19.44 | -30.44 | -30.01 | -28.52 | -14.65 | |
| Depreciation & Amortization | 2.5 | 2.66 | 2.5 | 1.1 | 0.79 | |
| Loss (Gain) From Sale of Assets | - | 0.05 | - | - | - | |
| Stock-Based Compensation | 3.19 | 5 | 4.37 | 3.47 | 2.2 | |
| Change in Accounts Payable | -0.08 | -0.54 | -0.98 | 1.51 | -0.32 | |
| Change in Other Net Operating Assets | 1.12 | -0.88 | 0.78 | -1.68 | -1.52 | |
| Operating Cash Flow | -12.71 | -24.15 | -23.34 | -24.12 | -13.51 | |
| Capital Expenditures | - | -0.19 | -0.6 | -3.71 | -0.31 | |
| Investing Cash Flow | - | -0.19 | -0.6 | -3.71 | -0.31 | |
| Long-Term Debt Repaid | -0.69 | -0.79 | -0.8 | -0.62 | -0.71 | |
| Net Debt Issued (Repaid) | -0.69 | -0.79 | -0.8 | -0.62 | -0.71 | |
| Issuance of Common Stock | 29.33 | 15.07 | 27.84 | 9.6 | 36.36 | |
| Other Financing Activities | - | -0.09 | - | - | -2.69 | |
| Financing Cash Flow | 28.64 | 14.18 | 27.04 | 8.99 | 32.96 | |
| Net Cash Flow | 15.93 | -10.15 | 3.1 | -18.84 | 19.14 | |
| Free Cash Flow | -12.71 | -24.34 | -23.94 | -27.83 | -13.82 | |
| Free Cash Flow Per Share | -2.91 | -13.63 | -24.05 | -39.81 | -41.58 | |
| Levered Free Cash Flow | -5.55 | -12.36 | -12.53 | -16.25 | -9.06 | |
| Unlevered Free Cash Flow | -5.55 | -12.36 | -12.53 | -16.25 | -9.06 | |
| Change in Working Capital | 1.04 | -1.41 | -0.2 | -0.17 | -1.84 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.